Jeff Yass’s Tenaya Therapeutics TNYA Stock Holding History

Jeff Yass’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.8K	Sell	44,300 -9,600	-18%	-$7.29K	﹤0.01%	12941
2026 Q1	$37.2K	Buy	53,900 +2,600	+5%	+$1.92K	﹤0.01%	12710
2025 Q4	$36.4K	Buy	51,300 +2,200	+4%	+$2.99K	﹤0.01%	11841
2025 Q3	$79.5K	Buy	49,100 +25,900	+112%	+$26.1K	﹤0.01%	11681
2025 Q2	$14.2K	Buy	+23,200	New	+$11.8K	﹤0.01%	12376
2025 Q1	–	Sell	-103,400	Closed	-$148K	–	13467
2024 Q4	$148K	Buy	+103,400	New	+$232K	﹤0.01%	11030
2023 Q3	–	Sell	-10,000	Closed	-$58.7K	–	12989
2023 Q2	$58.7K	Sell	10,000 -11,300	-53%	-$65.7K	﹤0.01%	11266
2023 Q1	$60.7K	Buy	+21,300	New	+$59.9K	﹤0.01%	11604

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's TNYA Position: Q2 2026 in Review

Jeff Yass increased its Tenaya Therapeutics (TNYA) stake by 5.4% in Q2 2026, buying an estimated $12.6K and bringing the position to 325,316 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #11559.

Jeff Yass first reported a position in TNYA in Q4 2022 and has held it in 14 quarters since. The position peaked at $575K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Jeff Yass held 325,316 shares of Tenaya Therapeutics worth $240K as of Q2 2026.
Jeff Yass bought 16,544 Tenaya Therapeutics shares in Q2 2026, an estimated $12.6K.
Tenaya Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11559 holding.
Jeff Yass first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 14 quarters since.
Jeff Yass's Tenaya Therapeutics position peaked at $575K in Q3 2025.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.